Lipid solubility, pKa and potency — and the apparent paradox at the centre of it: why alfentanil is faster than fentanyl despite being far less lipid soluble.
This single comparison is the most examined idea in opioid pharmacology, and it turns on pKa, not lipid solubility.
morphine < pethidine < alfentanil < fentanyl < sufentanil
| pKa | Lipid solubility | Onset | Defining feature | |
|---|---|---|---|---|
| Morphine | 8.0 | Lowest | Slow (peak 15–30 min) | M6G active metabolite, renally cleared — accumulates in renal failure |
| Pethidine | 8.7 | Low | Moderate | Norpethidine is proconvulsant; avoid with MAOIs |
| Alfentanil | 6.5 | 7× less than fentanyl | Fastest of the fentanyls | ~90% un-ionised at pH 7.4; small Vd (~25 L) |
| Fentanyl | 8.4 | High | Fast | High protein binding; context-sensitive half-time rises steeply with infusion |
| Sufentanil | 8.0 | Highest | Fast | Most potent — about 9× fentanyl |
| Remifentanil | 7.1 | High | Very fast | Non-specific plasma and tissue esterases; context-sensitive half-time constant at 3–4 min |
| Receptor | Effects |
|---|---|
| Mu (μ) | Analgesia (supraspinal and spinal), respiratory depression, euphoria, miosis, reduced gut motility, bradycardia, physical dependence |
| Kappa (κ) | Spinal analgesia, sedation, dysphagia and dysphoria, miosis, less respiratory depression |
| Delta (δ) | Analgesia, modulation of μ activity, some respiratory depression |
Built from handwritten page IMG_1283. Potency ratios and pKa values shown are the standard reference figures.